Evidence map›Paper›PMID 31919360›Full record

SynthesisNature communications2020

Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection.

Bo Li, Sara M Clohisey, Bing Shao Chia, Bo Wang, Ang Cui, Thomas Eisenhaure, Lawrence D Schweitzer, Paul Hoover, Nicholas J Parkinson, Aharon Nachshon and 15 more

Registry-linked trialOpen access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04750330 (Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection), which is not on this map. Cited by 156 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed, 7 pooled it
24.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04750330 completednot on this mapstarted 2021, after this paper: background citation

Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection

TypeobservationalSponsorMaastricht UniversityRan2021 to 2023Enrolled394ConditionsCovid19
3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 7 syntheses or guidelines pooled it, 241 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Early ADME and Preliminary Toxicity Studies of I-152, anChemical research in toxicology · 2026
    Article
  18. Article
  19. Article
  20. Article

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 3 countries.

Bo LiHarvard University Virology Program, Harvfvard Medical School, Boston, MA02142, USA.
Sara M ClohiseyRoslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK.ORCID http://orcid.org/0000-0001-7489-9846
Bing Shao ChiaHarvard University Virology Program, Harvfvard Medical School, Boston, MA02142, USA.
Bo WangRoslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK.ORCID http://orcid.org/0000-0002-1580-797X
Ang CuiBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA, 02142, USA.
Thomas EisenhaureBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA, 02142, USA.
Lawrence D SchweitzerBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA, 02142, USA.
Paul HooverBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA, 02142, USA.
Nicholas J ParkinsonRoslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK.
Aharon NachshonSchool of Molecular Cell Biology and Biotechnology, Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.ORCID http://orcid.org/0000-0003-2283-5220
Nikki SmithRoslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK.
Tim ReganRoslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK.ORCID http://orcid.org/0000-0002-0979-7875
David FarrRoslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK.
Michael U GutmannSchool of informatics, University of Edinburgh, Edinburgh, EH8 9YL, UK.
Syed Irfan BukhariCenter for Cancer Research, Massachusetts General hospital, Harvard Medical School, Boston, MA, USA.
Andrew LawRoslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK.ORCID http://orcid.org/0000-0003-1868-2364
Maya SangeslandThe Ragon Institute of Massachusetts General Hospital, MIT and Harvard University, Cambridge, MA, USA.
Irit Gat-ViksBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA, 02142, USA.
Paul DigardRoslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK.ORCID http://orcid.org/0000-0002-0872-9440
Shobha VasudevanCenter for Cancer Research, Massachusetts General hospital, Harvard Medical School, Boston, MA, USA.
Daniel LingwoodThe Ragon Institute of Massachusetts General Hospital, MIT and Harvard University, Cambridge, MA, USA.
David H DockrellMRC Center for Inflammation Research, University of Edinburgh, Edinburgh, UK.
John G DoenchBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA, 02142, USA.ORCID http://orcid.org/0000-0002-3707-9889
J Kenneth BaillieRoslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK. j.k.baillie@ed.ac.uk.ORCID http://orcid.org/0000-0001-5258-793X
Nir HacohenBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA, 02142, USA. nhacohen@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-2349-2656
Broad Institute · USRoslin Institute · GBHarvard University · USRagon Institute of MGH, MIT and Harvard · USCentre for Inflammation Research · GBTel Aviv University · ILUniversity of Edinburgh · GB

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Center for Cell CircuitsP50HG006193 · NHGRI · BROAD INSTITUTE, INC. · PI REGEV, AVIV · 2011 to 2015
$15.6M
Center for Cell CircuitsRM1HG006193 · NHGRI · BROAD INSTITUTE, INC. · PI BLAINEY, PAUL CLARK, HACOHEN, NIR · 2016 to 2020
$14.9M
Innate-like BCR activity as a template for universal vaccination against influenza virusR01AI137057 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CHACKERIAN, BRYCE C, LINGWOOD, DANIEL · 2018 to 2022
$2.6M
Defining and Exploiting a Genetic Template for an HIV VaccineDP2DA042422 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI LINGWOOD, DANIEL · 2016 to 2016
$2.6M
CDRH3-independent B cell stimulation to selectively expand VRC01 lineages from a fully humanized immunoglobulin repertoireR01AI124378 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CHACKERIAN, BRYCE C, LINGWOOD, DANIEL · 2017 to 2020
$2.0M
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNPR01GM100202 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI VASUDEVAN, SHOBHA · 2015 to 2019
$1.7M
Role of RNA methylation in chemoresistant cancer cellsR21CA220103 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI VASUDEVAN, SHOBHA · 2020 to 2021
$424k
Medical Research Council MR/N02995X/1NCI NIH HHS R21 CA220103NHGRI NIH HHS P50 HG006193NHGRI NIH HHS RM1 HG006193NIAID NIH HHS R01 AI124378NIAID NIH HHS R01 AI137057NIAID NIH HHS U19 AI057229NIDA NIH HHS DP2 DA042422NIGMS NIH HHS R01 GM100202U.S. Department of Health & Human Services | National Institutes of Health (NIH) NIH P50HG006193Wellcome TrustWellcome Trust (Wellcome) 103258/Z/13/Z
6 · The paper itself

Abstract

Host dependency factors that are required for influenza A virus infection may serve as therapeutic targets as the virus is less likely to bypass them under drug-mediated selection pressure. Previous attempts to identify host factors have produced largely divergent results, with few overlapping hits across different studies. Here, we perform a genome-wide CRISPR/Cas9 screen and devise a new approach, meta-analysis by information content (MAIC) to systematically combine our results with prior evidence for influenza host factors. MAIC out-performs other meta-analysis methods when using our CRISPR screen as validation data. We validate the host factors, WDR7, CCDC115 and TMEM199, demonstrating that these genes are essential for viral entry and regulation of V-type ATPase assembly. We also find that CMTR1, a human mRNA cap methyltransferase, is required for efficient viral cap snatching and regulation of a cell autonomous immune response, and provides synergistic protection with the influenza endonuclease inhibitor Xofluza.

Indexed as

A549 CellsAdaptor Proteins, Signal TransducingAntiviral AgentsCell LineClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsDibenzothiepinsGenetic Predisposition to DiseaseGenome-Wide Association StudyHost-Pathogen InteractionsHumansInfluenza A virusInfluenza, HumanMembrane ProteinsMethyltransferasesMorpholinesAdaptor Proteins, Signal TransducingAntiviral AgentsbaloxavirCcdc115 protein, humanDibenzothiepinsMembrane ProteinsMethyltransferasesMorpholinesmRNA (guanine(N7))-methyltransferaseNerve Tissue ProteinsOxazinesPyridinesPyridonesThiepinsTMEM199 protein, humanTriazinesVacuolar Proton-Translocating ATPasesWDR7 protein, human

Identifiers

PMID31919360
PMCPMC6952391
OpenAlexW3000124759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.